The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ProPhase Labs's share price is $4.95.
ProPhase Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.54. Hence, ProPhase Labs's PS Ratio for today is 1.95.
The historical rank and industry rank for ProPhase Labs's PS Ratio or its related term are showing as below:
PRPH'
s PS Ratio Range Over the Past 10 Years
Min: 0.91 Med: 1.98 Max: 12.79
Current: 1.95
During the past 13 years, ProPhase Labs's highest PS Ratio was 12.79. The lowest was 0.91. And the median was 1.98.
PRPH's PS Ratio is ranked better than 63.96% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.985
vs PRPH: 1.95
ProPhase Labs Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of ProPhase Labs was -60.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 27.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 38.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 22.80% per year.
During the past 13 years, ProPhase Labs's highest 3-Year average Revenue per Share Growth Rate was 124.20% per year. The lowest was -53.30% per year. And the median was 3.80% per year.
Back to Basics: PS Ratio
ProPhase Labs PS Ratio Historical Data
The historical data trend for ProPhase Labs's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ProPhase Labs's PS Ratio
For the Diagnostics & Research subindustry, ProPhase Labs's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProPhase Labs's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's PS Ratio distribution charts can be found below:
* The bar in red indicates where ProPhase Labs's PS Ratio falls into.
ProPhase Labs PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
ProPhase Labs's Share Price of today is $4.95. ProPhase Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
ProPhase Labs PS Ratio Related Terms
Thank you for viewing the detailed overview of ProPhase Labs's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ProPhase Labs (ProPhase Labs) Business Description
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRPH has been successfully added to your 